Cryo-Save is proud to announce the achievement of 200,000 samples stored from umbilical cord blood and umbilical cord tissue

November 22, 2011 Group News

Cryo-Save is proud to announce the storage of its 200,000th sample

This great achievement shows the successful results of Cryo-Save’s efforts in increasing the awareness of stem cell storage among the general public and the medical community. All samples stored can be considered as an outstanding source of stem cells, offering an enormous potential for treating so far incurable diseases.

read more

Director shareholding

November 3, 2011 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international family stem cell bank, has been informed that Mr Johan Goossens, Chairman, purchased 16,700 ordinary shares of Euro 0.10 (‘Ordinary Shares’) at a price of €4.14 on 1 November 2011.

Following this purchase, Mr Johan Goossens is beneficially interested in 1,316,703 ordinary shares, representing approximately 14.1% of the Group’s issued share capital.

read more

Cryo-Save launches educational program on clinical applications of stem cell therapies: an example of excellence in Serbia

October 28, 2011 Group News

Cryo-Save, Europe’s leading family stem cell bank launches an educational program on stem cell therapies. The aim of the program is to increase the awareness of stem cells therapy and regenerative medicine amongst healthcare professionals. Cryo-Save Serbia played a lead role in coordinating this annual event on Regenerative Medicine, Tissue and Genetic Engineering in Belgrade, Serbia earlier this October.

read more

GMP Certification awarded to Cryo-Save Lab, India

October 18, 2011 Group News

Cryo-Save becomes the first stem cell bank operating in India to receive the WHO-GMP certification

In a country where lack of stringent regulations has been causing the general public to view stem cell banking with a certain degree of trepidation, there is reason to cheer. Cryo-Save India, subsidiary of the leading Europe-based family stem cell banking company, has become the first to receive World Health Organisation – Good Manufacturing Procedures (WHO-GMP) certification.

read more

Cryo-Save opens new stem cell lab in Cape Town

September 13, 2011 Group News

Cryo-Save South Africa is pleased to announce the opening of its state-of-the-art stem cell processing and storage laboratory in Cape Town, South Africa.

The new laboratory is the result of the joint venture between Cryo-Save Group N.V. (Euronext: CRYO; “Cryo-Save Group”), the leading international family stem cell bank and JSE listed John Daniel Holdings Limited (JDH). JDH, through its subsidiary Lazaron Biotechnologies was the first company to successfully store cord blood stem cells in South Africa. The new joint venture company, which trades under the Cryo-Save brand, offers clients local and international storage options of umbilical cord tissue and stem cells from umbilical cord blood.

read more